Developments Anavex reports gut microbiota linked to improved ANAVEX2-73 response Anavex Life Sciences (NASDAQ:AVXL) reported that Alzheimer’s disease (AD) patients with high levels of two gut microbiota families had an improved response to ANAVEX2-73. ANAVEX2-73 is an orally-administered liquid... July 19, 2019